Trima
Trima is an Israeli pharmaceutical company that develops, manufactures, and markets generic Rx and OTC drugs across multiple therapeutic areas, operating an EU-GMP facility and serving both the Israeli market and international licensing partners.
- Company typePrivate
- Founded1935
- HeadquartersAgudat Israel, Israel
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Trima does
Trima is an Israeli pharmaceutical company specializing in the development, manufacturing, and marketing of generic drugs, founded in 1935 and wholly owned by Kibbutz Ma'abarot since 2018. The company operates an EU-GMP certified production facility in Ma'abarot, Israel, manufacturing Rx and OTC pharmaceuticals in tablets, capsules, gels, creams, powders, syrups, and sprays across therapeutic areas including dermatology, respiratory, CNS, muscular-skeletal pain, allergy, and cough/cold. Its portfolio comprises over 60 internally developed generic products plus approximately 10 licensed/imported products distributed in the Israeli market.
Trima runs a vertically integrated value chain covering R&D, regulatory affairs, manufacturing, logistics, and sales and marketing. The company pursues a dual business model: (1) proprietary generic drug development and direct sales to Israeli institutional buyers and the private market, and (2) partnership-driven distribution — in-licensing international Rx, OTC, and medical device products for the Israeli market, and out-licensing its in-house developed products to international partners for private label and distribution arrangements.
Leadership is drawn from major pharmaceutical companies including Teva, Taro Pharmaceuticals, and Johnson & Johnson. Trima maintains a global partner network including Dr Fisher, Cooper, Grimberg, BMG Pharma, HARRAS, Megapharm, Trenker, Gedeon Richter, Kern, Velit, Aldo Union, and Pramit. The company is currently expanding capacity through construction of a new manufacturing campus at its Kibbutz Ma'abarot site.
Trima firmographics
Firmographics- Name
- Trima
- Legal name
- Trima Israel Pharmaceutical Products Maabrot Ltd.
- Website
- https://trima.co.il
- Company type
- Private
- Founded year
- 1935
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Trima is an Israeli pharmaceutical company that develops, manufactures, and markets generic Rx and OTC drugs across multiple therapeutic areas, operating an EU-GMP facility and serving both the Israeli market and international licensing partners.
- Ownership category
- akta.pro rank
Trima industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)
- akta.pro secondary industry
- Generic Hospital & Institutional Products (HLAIABAL)
Keywords
Where Trima is headquartered
LocationHeadquarters
- HQ city
- Agudat Israel
- HQ country
- Israel
- HQ region
- Middle East
Offices3 records
Markets served
Trima business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Generic Drug Manufacturing and Sales: Development, manufacturing and marketing of internally developed generic pharmaceutical products including Rx and OTC drugs across multiple therapeutic areas
- In-Licensing and Distribution: Partnering with international companies to license, register, and distribute their products (Rx, OTC, Medical Devices) in the Israeli market, handling regulatory support, logistics, and sales and marketing
- Out-Licensing and Private Label: Expanding marketing partnerships for products developed in-house, providing regulatory support, flexible manufacturing capabilities and logistics to partners
Go-to-market motion2 records
Distribution channels2 records
Marketing channels2 records
Trima product offering
Product offeringCore offering
Trima develops, manufactures, and markets a portfolio of generic pharmaceutical products (Rx and OTC) in multiple dosage forms including tablets, capsules, creams, gels, ointments, powders, syrups, and sprays. Its offering includes over 60 internally developed generic products plus approximately 10 licensed/imported products distributed in Israel. The company also provides in-licensing and distribution services for international pharma companies entering the Israeli market, and out-licensing/private label services for its own in-house developed products.
Product overview
Trima is a pharmaceutical company offering a unified portfolio centered on generic drug development, manufacturing, and marketing. The portfolio consists of over 60 internally developed generic pharmaceutical products (Rx and OTC) plus approximately 10 licensed/imported products, spanning therapeutic areas including dermatology, respiratory, CNS, muscular-skeletal pains, allergy, and cough and cold. Products are manufactured in various forms including tablets, capsules, creams, gels, ointments, powders, syrups, and sprays. Complementing the product portfolio, Trima provides in-licensing and distribution services for international partners seeking market entry, as well as out-licensing and private label services enabling partners to market Trima's in-house developed products.
Differentiator
Problem solved
Functional benefit
Products and services
- Generic Pharmaceuticals (Internal Development) Over 60 generic pharmaceutical products developed internally at Trima, including Rx (prescription) and OTC (over-the-counter) drugs across therapeutic areas including dermatology, respiratory, CNS, muscular-skeletal pains, allergy, and cough and cold. Manufactured at the EU-GMP certified facility in Israel in forms such as tablets, capsules, creams, gels, ointments, powders, syrups, and sprays.
- Licensed / Imported Pharmaceutical Products
Companies that use Trima
Customer profileSegments2 records
Ideal customer profiles2 records
Trima technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Trima partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core.
- Dr FishercoreLogo partner displayed on Trima website as part of global partners section, indicating collaborative relationship for product distribution or marketing.
- CoopercoreLogo partner displayed on Trima website as part of global partners section, indicating collaborative relationship for product distribution or marketing.
- GrimbergcoreLogo partner displayed on Trima website as part of global partners section, indicating collaborative relationship for product distribution or marketing.
- BMG PharmacoreLogo partner displayed on Trima website as part of global partners section, indicating collaborative relationship for product distribution or marketing.
- HARRAScoreLogo partner displayed on Trima website as part of global partners section, indicating collaborative relationship for product distribution or marketing.
- MegapharmcoreLogo partner displayed on Trima website as part of global partners section, indicating collaborative relationship for product distribution or marketing.
- TrenkercoreLogo partner displayed on Trima website as part of global partners section, indicating collaborative relationship for product distribution or marketing.
- Gedeon RichtercoreLogo partner displayed on Trima website as part of global partners section, indicating collaborative relationship for product distribution or marketing.
- KerncoreLogo partner displayed on Trima website as part of global partners section, indicating collaborative relationship for product distribution or marketing.
- VelitcoreLogo partner displayed on Trima website as part of global partners section, indicating collaborative relationship for product distribution or marketing.
- Aldo UnioncoreLogo partner displayed on collaborations page, indicating partnership for in-licensing, distribution or collaborative product efforts.
- PramitcoreLogo partner displayed on collaborations page, indicating partnership for in-licensing, distribution or collaborative product efforts.
Scale indicators5 records
Recent moves10 records
Expansion highlights4 records
Trima competitors and assessment
Company assessmentBroad incumbents
- Teva Pharmaceutical Industries: Israel's largest generic drug manufacturer and a global broad incumbent in pharmaceuticals. Comparably positioned as an Israeli generic pharma with R&D, manufacturing, and commercial operations, though at vastly larger scale and global reach than Trima.
- Taro Pharmaceutical Industries: Israeli generic and specialty pharmaceutical company, formerly led by Trima's current Chairman Shmuel Rubinstein. Comparable as an Israel-headquartered generic drug manufacturer with multi-form capabilities serving both U.S. and international markets.
- Perrigo Company: Global leader in consumer self-care and generic pharmaceuticals with strong OTC/Rx portfolio. Comparable as a broad incumbent in branded generics and OTC manufacturing, though operating at significantly larger scale across multiple geographies.
- Viatris: Global healthcare company formed from Mylan and Upjohn with extensive generic and branded pharmaceutical portfolio. Comparable as a broad incumbent in multi-form generic manufacturing across multiple therapeutic areas.
- Sandoz (Novartis): Global leader in generic pharmaceuticals and biosimilars, spun off from Novartis. Comparable as a broad incumbent in generic drug development and manufacturing across diverse dosage forms and therapeutic categories.
- Dr. Reddy's Laboratories: Indian-headquartered global pharmaceutical company with strong generics portfolio across multiple dosage forms. Comparable as a broad incumbent offering branded generics and active pharmaceutical ingredients internationally.
- Gedeon Richter: Hungarian-headquartered multinational pharmaceutical company with generics and specialty pharma operations. Comparable as a European-headquartered broad incumbent in generic drug manufacturing with whom Trima has a listed partnership relationship.
Direct peers
- Dexcel Pharma Israel: Israel-based specialty and generic pharmaceutical company with development, manufacturing, and marketing operations. Directly comparable in size, Israeli market focus, generic drug portfolio, and multi-form manufacturing capabilities.
- Unipharm Israel: Israeli pharmaceutical manufacturer that was historically Trima's partner through Motivan. Directly comparable as an Israel-based generic pharma with overlapping therapeutic categories and private-label/in-licensing business model.
- Megapharm: Israeli pharmaceutical company focused on marketing and distribution of pharmaceutical products. Directly comparable as an Israel-based pharma partner in Trima's in-licensing network, operating with similar Israeli-market focus.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Trima social profiles
Digital presenceTrima compliance and trust
Trust signalCompliance3 records
Trima financial estimates
Financial estimateRevenue estimate
Valuation estimate
Trima leadership team
Management profileNumber of profiles
Profiles9 records
Trima funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Trima M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Trima
What does Trima do?
Trima develops, manufactures, and markets a portfolio of generic pharmaceutical products (Rx and OTC) in multiple dosage forms including tablets, capsules, creams, gels, ointments, powders, syrups, and sprays. Its offering includes over 60 internally developed generic products plus approximately 10 licensed/imported products distributed in Israel. The company also provides in-licensing and distribution services for international pharma companies entering the Israeli market, and out-licensing/private label services for its own in-house developed products.
Is Trima a public or private company?
Trima is a private company. It is classified as corporate owned and is currently operating.
When was Trima founded?
Trima was founded in 1935. It employs 11 to 50 people.
Where is Trima based?
Trima is headquartered in Agudat Israel, Israel, in the Middle East region.
How does Trima make money?
Three revenue lines are on record. Generic Drug Manufacturing and Sales are the primary driver. The others are in-Licensing and Distribution and out-Licensing and Private Label.
Who are Trima's main competitors?
Broad incumbents on record are Teva Pharmaceutical Industries, Taro Pharmaceutical Industries, Perrigo Company, Viatris, Sandoz (Novartis), Dr. Reddy's Laboratories and Gedeon Richter. Direct peers are Dexcel Pharma Israel, Unipharm Israel and Megapharm.
Does Trima have an API?
No public API is recorded for Trima.
What industry is Trima in?
Trima's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAA, Small-Molecule Generics (Branded/Unbranded), with a secondary code of HLAIABAL, Generic Hospital & Institutional Products. Its NAICS code is 325412 and its SIC code is 2834.